Analyzing Sensus Healthcare (NASDAQ:SRTS) and Vivos Therapeutics (NASDAQ:VVOS)

Sensus Healthcare (NASDAQ:SRTS) and Vivos Therapeutics (NASDAQ:VVOS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

Analyst Ratings

This is a summary of current ratings and recommmendations for Sensus Healthcare and Vivos Therapeutics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	0	0	2	1	3.33
Vivos Therapeutics	0	0	2	0	3.00

Sensus Healthcare presently has a consensus price target of $12.50, suggesting a potential upside of 90.55%. Vivos Therapeutics has a consensus price target of $6.30, suggesting a potential upside of 9.76%. Given Sensus Healthcare’s stronger consensus rating and higher possible upside, equities analysts plainly believe Sensus Healthcare is more favorable than Vivos Therapeutics.

Institutional and Insider Ownership

25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 26.4% of Vivos Therapeutics shares are owned by institutional investors. 9.4% of Sensus Healthcare shares are owned by company insiders. Comparatively, 3.0% of Vivos Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Sensus Healthcare and Vivos Therapeutics”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$24.41 million	4.40	$490,000.00	$0.57	11.51
Vivos Therapeutics	$13.80 million	2.01	-$13.58 million	($5.68)	-1.01

Sensus Healthcare has higher revenue and earnings than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Sensus Healthcare has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, Vivos Therapeutics has a beta of 7.51, meaning that its share price is 651% more volatile than the S&P 500.

Profitability

This table compares Sensus Healthcare and Vivos Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	22.54%	17.99%	16.26%
Vivos Therapeutics	-86.19%	-335.04%	-93.58%

Summary

Sensus Healthcare beats Vivos Therapeutics on 12 of the 14 factors compared between the two stocks.

About Sensus Healthcare

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

About Vivos Therapeutics

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.